"AICR ( Austin Institute for Clinical Research) at Pflugerville is a world-class dermatology research organization specializing in clinical trials that focus on treatment of skin conditions. Since 2013, we have worked diligently in the dermatology community as a research site that provides meticulous attention to detail, dedicated patient care and excellent data capture. As the largest multisite research organization and private dermatology practice in the United States, we offer the following benefits: -Simplified logistics via a dedicated, centralized team -Dedicated research personnel and dermatologists at each location -Unmatched access to a pool of potential trial participants"

During the past decade, Austin Institute for Clinical Research, Inc. conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 42 clinical trials were completed, i.e. on average, 56% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 28 clinical trials were completed. i.e. 107.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Austin Institute for Clinical Research, Inc." #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Pfizer" with 9 trials sponsored, "Amgen" with 5 trials sponsored, "Concert Pharmaceuticals" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Institute for Clinical Research, Inc." #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Accelovance" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "Athenex, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Austin Institute for Clinical Research, Inc." are "Acne Vulgaris" (11 trials), "Atopic Dermatitis" (8 trials), "Psoriasis" (8 trials), "Plaque Psoriasis" (7 trials) and "Alopecia Areata" (5 trials). Many other conditions were trialed in "Austin Institute for Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "Austin Institute for Clinical Research, Inc." are "Drug" (71 trials), "Other" (13 trials), "Biological" (7 trials), "Device" (6 trials) and "Combination Product" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Vehicle" (4 trials), "Apremilast" (3 trials), "Baricitinib" (3 trials) and "CTP-543" (3 trials). Other intervention names were less common.

The vast majority of trials in "Austin Institute for Clinical Research, Inc." are 87 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Austin Institute for Clinical Research, Inc.". undefined are not yet recruiting, 8 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 60 completed trials in Austin Institute for Clinical Research, Inc., undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Austin Institute for Clinical Research, Inc., 2 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".

Austin Institute for Clinical Research, Inc. has several departments that took part in Clinical trials: "Pflugerville Dermatology Clinical Research Center, Inc." - 2 trials